GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.27) per share. The company reported $1.73 million in sales this quarter.
SEC Chair Gary Gensler Now Appearing On Bloomberg TV
https://twitter.com/GaryGensler/status/1563159948892131328